Dual‑payload antibody‑drug conjugates in triple‑negative breast cancer: Preclinical advances and future perspectives (Review)
World Academy of Sciences Journal · 30.10.2026 · 8 (6) · 1-10
DOI: 10.3892/wasj.2026.521 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Academy of Sciences Journal, online erschienen am 30.10.2026. Verfasst von Rahmah Syala und 3 weiteren Autor:innen. Die Arbeit nennt 89 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Syala, R., Younus, E., Abed, M., & Alassaf, F. (2026). Dual‑payload antibody‑drug conjugates in triple‑negative breast cancer: Preclinical advances and future perspectives (Review). World Academy of Sciences Journal, 8(6), 1-10. https://doi.org/10.3892/wasj.2026.521
Vancouver
Syala R, Younus E, Abed M, Alassaf F. Dual‑payload antibody‑drug conjugates in triple‑negative breast cancer: Preclinical advances and future perspectives (Review). World Academy of Sciences Journal. 2026;8(6):1-10. doi:10.3892/wasj.2026.521
BibTeX
@article{Syala2026,
author = {Syala, Rahmah and Younus, Esraa and Abed, Mohammed and Alassaf, Fawaz},
title = {Dual‑payload antibody‑drug conjugates in triple‑negative breast cancer: Preclinical advances and future perspectives (Review)},
journal = {World Academy of Sciences Journal},
year = {2026},
volume = {8},
number = {6},
pages = {1--10},
doi = {10.3892/wasj.2026.521}
}
EUVIMED